323-330
Review Article
Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients
Maria Jose Solana and Jesús López-Herce
331-340
Review Article
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
Zoltán Kiss, Steven Elliott, Kinga Jedynasty, Vladimír Tesar and János Szegedi
341-347
Special Article
Unbalanced reporting of benefits and harms in abstracts on rofecoxib
Anders W. Jørgensen, Karsten Juhl Jørgensen and Peter C. Gøtzsche
349-357
Clinical Trial
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
Filip Josephson, Maria C. H. Andersson, Leo Flamholc, Magnus Gisslén and Lars Hagberg, et al.
359-368
Pharmacodynamics
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria
Antonia C. Kastoris, Petros I. Rafailidis, Evridiki K. Vouloumanou, Ioannis D. Gkegkes and Matthew E. Falagas
369-374
Pharmacogenetics
Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example
Alain Li-Wan-Po, Peter Farndon, Charles Craddock and Michael Griffiths
375-381
Pharmacokinetics and Disposition
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting
Annette Haberl, Manfred Moesch, Gabriele Nisius, Christoph Stephan and Markus Bickel, et al.
383-386
Pharmacokinetics and Disposition
CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity
Henrik Gréen, Karin Skoglund, Franz Rommel, Rajaa A. Mirghani and Kourosh Lotfi
387-397
Pharmacokinetics and Disposition
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone
Teijo I. Saari, Juha Grönlund, Nora M. Hagelberg, Mikko Neuvonen and Kari Laine, et al.
399-406
Pharmacoepidemiology and Prescription
Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study
Øystein Karlstad, Per Nafstad, Aage Tverdal, Svetlana Skurtveit and Kari Furu
407-412
Pharmacoepidemiology and Prescription
Open AccessDo medical students copy the drug treatment choices of their teachers or do they think for themselves?
J. Tichelaar, M. C. Richir, H. J. Avis, H. J. Scholten and N. F. Antonini, et al.
413-417
Pharmacoepidemiology and Prescription
Drug dependence associated with triptans and ergot derivatives: a case/non-case study
Frédérique Beau-Salinas, Annie Pierre Jonville-Béra, Haware Cissoko, Lamiae Bensouda-Grimaldi and Elisabeth Autret-Leca
419-426
Pharmacoepidemiology and Prescription
The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study
Henriette Farkas, Ibolya Czaller, Dorottya Csuka, Anikó Vas and Szilvia Valentin, et al.
427-428
Letter to the Editors
Possible hepatotoxic effect of rooibos tea: a case report
Marjatta Sinisalo, Anna-Liisa Enkovaara and Kari T. Kivistö